Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ·Healthcare·Biotechnology
$9.70
-3.77%
Mkt Cap $119.71M
Analyst Ratings
No recent rating data.
Price Target (13 analysts)
$43.33
Range $39.00 – $51.00
Implied Upside
+346.7%
Consensus $43.33 vs current $9.70